Sanofi
CIK: 0001121404
10% Owner
Primary company: REGENERON PHARMACEUTICALS, INC. (REGN)
Sanofi is a corporate insider at REGENERON PHARMACEUTICALS, INC. (REGN) filing SEC Form 4 transactions. 581 transactions across 9 companies, totaling $7,230,996,376 in purchases and $12,110,262,343 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Conversion | 177,978 | - | - | 0 | 8/10/2026 Filed: 8/10/2026 | Filing → | |
| Conversion | 494,800 | - | - | 0 | 8/10/2026 Filed: 8/10/2026 | Filing → | |
| Conversion | 177,978 | - | - | 672,788 | 8/10/2026 Filed: 8/10/2026 | Filing → | |
| Conversion | 494,800 | - | - | 494,800 | 8/10/2026 Filed: 8/10/2026 | Filing → | |
| Conversion | 782,855 | - | - | 0 | 8/6/2026 Filed: 8/6/2026 | Filing → | |
| Purchase | 300,000 | $17.00 | $5.10M | 1,082,855 | 8/6/2026 Filed: 8/6/2026 | Filing → | |
| Conversion | 782,855 | - | - | 782,855 | 8/6/2026 Filed: 8/6/2026 | Filing → | |
Translate Bio, Inc. TBIO | Purchase | 20,515,985 | $38.00 | $779.61M | 75,668,031 | 9/14/2021 Filed: 9/14/2021 | Filing → |
Translate Bio, Inc. TBIO | Purchase | 51,467,612 | $38.00 | $1955.77M | 55,152,046 | 9/14/2021 Filed: 9/14/2021 | Filing → |
Icosavax, Inc. ICVX | Conversion | 354,393 | - | - | 0 | 8/2/2021 Filed: 8/2/2021 | Filing → |
Icosavax, Inc. ICVX | Conversion | 12,480,498 | - | - | 0 | 8/2/2021 Filed: 8/2/2021 | Filing → |
Icosavax, Inc. ICVX | Purchase | 66,667 | $15.00 | $1.00M | 3,155,169 | 8/2/2021 Filed: 8/2/2021 | Filing → |
Icosavax, Inc. ICVX | Conversion | 3,088,502 | $0.00 | $0 | 3,088,502 | 8/2/2021 Filed: 8/2/2021 | Filing → |
Inozyme Pharma, Inc. INZY | Conversion | 3,279,720 | $0.00 | $0 | 0 | 7/28/2020 Filed: 7/29/2020 | Filing → |
Inozyme Pharma, Inc. INZY | Purchase | 81,250 | $16.00 | $1.30M | 520,125 | 7/28/2020 Filed: 7/29/2020 | Filing → |
Inozyme Pharma, Inc. INZY | Conversion | 438,875 | $0.00 | $0 | 438,875 | 7/28/2020 Filed: 7/29/2020 | Filing → |
| Sale | 120,234 | $597.48 | $71.84M | 279,766 | 6/9/2020 Filed: 6/11/2020 | Filing → | |
| Sale | 2,399,552 | $509.85 | $1223.41M | 400,000 | 5/29/2020 Filed: 5/29/2020 | Filing → | |
| Sale | 20,421,899 | $509.85 | $10412.11M | 0 | 5/29/2020 Filed: 5/29/2020 | Filing → | |
| Sale | 128,914 | $489.65 | $63.12M | 20,421,899 | 3/9/2020 Filed: 3/11/2020 | Filing → |
Type
Conversion
Shares
177,978
Price
-
Value
-
Type
Conversion
Shares
494,800
Price
-
Value
-
Type
Conversion
Shares
177,978
Price
-
Value
-
Type
Conversion
Shares
494,800
Price
-
Value
-
Type
Conversion
Shares
782,855
Price
-
Value
-
Type
Purchase
Shares
300,000
Price
$17.00
Value
$5.10M
Type
Conversion
Shares
782,855
Price
-
Value
-
Translate Bio, Inc.
TBIO
Type
Purchase
Shares
20,515,985
Price
$38.00
Value
$779.61M
Translate Bio, Inc.
TBIO
Type
Purchase
Shares
51,467,612
Price
$38.00
Value
$1955.77M
Icosavax, Inc.
ICVX
Type
Conversion
Shares
354,393
Price
-
Value
-
Icosavax, Inc.
ICVX
Type
Conversion
Shares
12,480,498
Price
-
Value
-
Icosavax, Inc.
ICVX
Type
Purchase
Shares
66,667
Price
$15.00
Value
$1.00M
Icosavax, Inc.
ICVX
Type
Conversion
Shares
3,088,502
Price
$0.00
Value
$0
Inozyme Pharma, Inc.
INZY
Type
Conversion
Shares
3,279,720
Price
$0.00
Value
$0
Inozyme Pharma, Inc.
INZY
Type
Purchase
Shares
81,250
Price
$16.00
Value
$1.30M
Inozyme Pharma, Inc.
INZY
Type
Conversion
Shares
438,875
Price
$0.00
Value
$0
Type
Sale
Shares
120,234
Price
$597.48
Value
$71.84M
Type
Sale
Shares
2,399,552
Price
$509.85
Value
$1223.41M
Type
Sale
Shares
20,421,899
Price
$509.85
Value
$10412.11M
Type
Sale
Shares
128,914
Price
$489.65
Value
$63.12M
AI Agent
Try asking...